17, 2012 (GLOBE NEWSWIRE) — LifeVantage Corporation /quotes/zigman/452058 LFVN 0.00% , maker of Protandim(R), the Nrf2 Synergizer(TM) patented dietary suppleme.
The Company's primary product, Protandim, a dietary supplement, has been clinically proven to reduce the effects of oxidative stress, as well as the progres.
17, 2012 (GLOBE NEWSWIRE) — LifeVantage Corporation /quotes/zigman/452058 LFVN 0.00% , maker of Protandim(R), the Nrf2 Synergizer(TM) patented dietary suppleme.
17, 2012 (GLOBE NEWSWIRE) — LifeVantage Corporation /quotes/zigman/452058 LFVN 0.00% , maker of Protandim(R), the Nrf2 Synergizer(TM) patented dietary suppleme.
The stock which currently resides at about a dollar and a half is still a good buy according to analysts based on the performance of its primary product, Protandim. Protandim is a dietary supplement which has been clinically proven to reduce the
Related posts:
- Protandim Supplement Anti-Aging Drug Causes Surge in Stock Price for Parent …
- Protandim Supplement Anti-Aging Drug Causes Surge in Stock Price for Parent …
- LifeVantage to Announce Fiscal Second Quarter 2012 Results on February 14, 2012
- NFLX stock jumps, as Netflix audience returns
- MPAA's Dodd warns Washington not to let pirates sink PIPA/SOPA